Bloomberg News

D.N.A. Biomedical Wins FDA Approval to Market MinOmni Product

October 16, 2011

Oct. 16 (Bloomberg) -- D.N.A. Biomedical Solutions Ltd. won approval from the U.S. Food & Drug Administration to market its MiniOmni device in the U.S., the company said in a statement to the Tel Aviv Stock Exchange today.

To contact the reporter on this story: Gwen Ackerman in Jerusalem at gackerman@bloomberg.net

To contact the editor responsible for this story: Gwen Ackerman at gackerman@bloomberg.net


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus